Receive our newsletter – data, insights and analysis delivered to you
  1. News
September 28, 2021

LTI and eClinicalHealth partner to decentralise clinical trials

As part of the partnership, LTI will help expedite the joint go-to-market pursuits and the deployment for Clinpal adopters.

Larsen & Toubro Infotech (LTI) and eClinicalHealth have signed a strategic partnership to help decentralise clinical trials for faster outcomes.

The collaboration is aimed at accelerating digital innovation in the research and development of the clinical trials management process for patient-centric drug development.

LTI stated that 86% of clinical trials are delayed due to the challenges faced in patient engagement, including recruiting and retaining patients.

eClinicalHealth has launched Clinpal, a Cloud-based patient-centric software-as-service (SaaS) solution, to address this challenge.

Clinpal is an end-to-end, direct-to-patient digital clinical trials platform that improves patient engagement throughout each clinical trial.

LTI Life Sciences, Media, Consumer and Technology executive vice-president and global delivery head Archana Ramanakumar said: “At LTI, we are on a journey to drive digital transformation for various aspects of clinical trials.

Content from our partners
Africa’s last mile: Building viable vaccine supply chains
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
Patient-centric pharma logistics: How CRYOPDP delivers hope worldwide

“Our endeavour with eClinicalHealth partnership is to accelerate and streamline the enablement of decentralised trials, to reduce patient burden and drive acceleration of clinical trials.

“With this partnership, we aim to accelerate the development and deployment of eClinicalHealth’s ClinPal platform in clinical trials for the industry.”

As part of the strategic collaboration, the company will help accelerate the joint go-to-market pursuits and the deployment for Clinpal adopters, using its digital, technical and life sciences domain capabilities.

Clinpal will use exponential technologies such as analytics and artificial intelligence (AI) to improve patient engagement and quicker clinical studies.

eClinicalHealth board chairman and CEO Karl Landert said: “The new normal world has put into limelight the benefits of a telemedicine ecosystem for the larger benefit of end-users.

“With our strategic partnership with LTI, our aim is to further scale and simplify patient engagement.”

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU